Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Brain Research

• Publication date

  2013-07-26

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.brainres.2013.05.046PMID 23747813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective Effect of Puerarin on Nerve Cells in Substantia Nigra of Parkinson's Disease Rats Induced by 6-hydroxydopamine

  2013cited by this paper
• Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel

  2013cited by this paper
• Puerarin protects differentiated PC12 cells from H2O2‐induced apoptosis through the PI3K/Akt signalling pathway

  2012cited by this paper
• Mitochondria as an easy target to oxidative stress events in Parkinson's disease.

  2012cited by this paper
• Mitochondrial Dynamics and Mitophagy in the 6-Hydroxydopamine Preclinical Model of Parkinson's Disease

  2012cited by this paper
• Advances in metal-induced oxidative stress and human disease.

  2011cited by this paper
• Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway.

  2011cited by this paper
• Postsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and disease

  2010cited by this paper
• Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.

  2010cited by this paper
• Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment

  2010cited by this paper
• Nrf2:INrf2 (Keap1) signaling in oxidative stress.

  2009cited by this paper
• Nrf 2 : INrf 2 ( Keap 1 ) Signaling in Oxidative Stress

  2009cited by this paper
• Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases

  2009cited by this paper
• Oxidative Stress in Parkinson's Disease

  2008cited by this paper
• The Nrf2–ARE Pathway

  2008cited by this paper
• Mechanism of 6‐hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6‐hydroxydopamine‐induced degeneration of dopaminergic neurons

  2007cited by this paper
• Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity

  2007cited by this paper
• Assembly of mitochondrial cytochrome c-oxidase, a complicated and highly regulated cellular process.

  2006cited by this paper
• Parkinson's disease: diagnosis and treatment.

  2006cited by this paper
• Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway

  2006cited by this paper
• Molecular Mechanism of Nrf2 Activation by Oxidative Stress

  2005cited by this paper
• The study of anti-metabolic syndrome effect of puerarin in vitro.

  2005cited by this paper
• The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats.

  2005cited by this paper
• The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.

  2005cited by this paper
• Differential effects of endogenous brain-derived neurotrophic factor on the survival of axotomized sensory neurons in dorsal root ganglia: a possible role for the p75 neurotrophin receptor.

  2005cited by this paper
• Genetic defects of cytochrome c oxidase assembly.

  2004cited by this paper
• Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP

  2004cited by this paper
• The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress.

  2004influential reference
• Parkinson's disease

  2004cited by this paper
• [The clinical observation of puerarin injection on unstable angina pectoris].

  2004cited by this paper
• Role of oxygen radicals in DNA damage and cancer incidence

  2004cited by this paper
• Differential expression of the lenticular antioxidant system in laboratory animals: A determinant of species predilection to oxidative stress-induced ocular toxicity?

  2003cited by this paper
• Oxidative stress in Parkinson's disease

  2003cited by this paper
• Parkinson's disease. Therapeutic strategies to improve patient function and quality of life.

  2002cited by this paper
• Neurotrophins: roles in neuronal development and function.

  2001cited by this paper
• Regulation of gamma-glutamylcysteine synthetase expression in response to oxidative stress.

  1999cited by this paper
• Regulation of γ-glutamycysteine synthetase expression in response to oxidative stress

  1999cited by this paper
• Parkinson's disease. Diagnosis and treatment.

  1996cited by this paper
• BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

  1991cited by this paper
• Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior.

  1991cited by this paper
• The rotational behavior model: asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats.

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress.

  2026cites this paper
• Modulation of nitric oxide signaling by flavonoids: implications for neurodegeneration

  2025cites this paper
• Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases

  2024cites this paper
• Effects of puerarin on gait disturbance in a 6-hydroxydopamine mouse model of Parkinson’s disease

  2024cites this paper
• Pharmacological mechanisms of puerarin in the treatment of Parkinson's disease: An overview.

  2024cites this paper
• Flavonoids in Combination with Stem Cells for the Treatment of Neurological Disorders

  2023cites this paper
• Sericin alleviates motor dysfunction by modulating inflammation and TrkB/BDNF signaling pathway in the rotenone-induced Parkinson’s disease model

  2023cites this paper
• Therapeutic potential of puerarin against cerebral diseases: From bench to bedside.

  2023cites this paper
• Puerarin: a potential natural neuroprotective agent for neurological disorders.

  2023cites this paper
• Potential implications of polyphenolic compounds in neurodegenerative diseases

  2022cites this paper
• Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update

  2022cites this paper
• Recent development in nanocrystals based drug delivery for neurodegenerative disease: Scope, challenges, current and future prospects

  2021cites this paper
• Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives

  2021cites this paper
• Microenvironment-tailored nanoassemblies for the diagnosis and therapy of neurodegenerative diseases.

  2021cites this paper
• Perillyl Alcohol Mitigates Behavioural Changes and Limits Cell Death and Mitochondrial Changes in Unilateral 6-OHDA Lesion Model of Parkinson’s Disease Through Alleviation of Oxidative Stress

  2020cites this paper
• Metabolic responses of BV-2 cells to puerarin on its polarization using ultra-performance liquid chromatography-mass spectrometry.

  2020cites this paper
• Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson’s disease models

  2020cites this paper
• Anti–coronavirus disease 2019 (COVID‐19) targets and mechanisms of puerarin

  2020cites this paper
• Botanical Drug Puerarin Promotes Neuronal Survival and Neurite Outgrowth against MPTP/MPP+-Induced Toxicity via Progesterone Receptor Signaling

  2020cites this paper
• An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases

  2020cites this paper
• Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy.

  2019cites this paper
• Neurotrophic properties and the de novo peptide sequencing of edible bird's nest extracts

  2019cites this paper
• Puerarin alleviates streptozotocin (STZ)-induced osteoporosis in rats through suppressing inflammation and apoptosis via HDAC1/HDAC3 signaling.

  2019cites this paper
• Targeting Ubiquitin Proteasome Pathway with Traditional Chinese Medicine for Treatment of Spinocerebellar Ataxia Type 3.

  2019cites this paper
• Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson’s Disease Models

  2019cites this paper
• Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease.

  2019cites this paper
• Activity Dependent Mammalian Target of Rapamycin Pathway and Brain Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Effects of Puerarin.

  2018cites this paper
• The Phenolic Components of Gastrodia elata improve Prognosis in Rats after Cerebral Ischemia/Reperfusion by Enhancing the Endogenous Antioxidant Mechanisms

  2018cites this paper
• Puerarin promoted proliferation and differentiation of dopamine-producing cells in Parkinson's animal models.

  2018cites this paper
• Natural Phytoestrogens: A Class of Promising Neuroprotective Agents for Parkinson Disease

  2018cites this paper
• Brain-Derived Neurotrophic Factor Increases Synaptic Protein Levels via the MAPK/Erk Signaling Pathway and Nrf2/Trx Axis Following the Transplantation of Neural Stem Cells in a Rat Model of Traumatic Brain Injury

  2017cites this paper
• Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model

  2017cites this paper
• Nöroprotektif Etkili Bir Flavonoid: Nobiletin

  2017cites this paper
• Current Understanding on the Beneficial Role of Nutrition in ParkinsonâÂÂsDisease âÂÂAn Overview

  2017cites this paper
• Antioxidant therapies in traumatic brain injury: a review

  2017cites this paper
• Lumbee traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.

  2017cites this paper
• Dietary Phytochemicals in Neurodegenerative Disease

  2017cites this paper
• Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms

  2017cites this paper
• Radix Puerariae modulates glutamatergic synaptic architecture and potentiates functional synaptic plasticity in primary hippocampal neurons.

  2017cites this paper
• Current Understanding on the Beneficial Role of Nutrition in Parkinson’s Disease –An Overview

  2017cites this paper
• Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides.

  2017cites this paper
• Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats.

  2016cites this paper
• Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidants for Prevention and Improved Management of Parkinson’s Disease

  2016cites this paper
• Puerarin Protects Human Neuroblastoma SH‐SY5Y Cells against Glutamate‐Induced Oxidative Stress and Mitochondrial Dysfunction

  2016cites this paper
• An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.

  2015cites this paper
• Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

  2015cites this paper
• Botanical Drug Puerarin Coordinates with Nerve Growth Factor in the Regulation of Neuronal Survival and Neuritogenesis via Activating ERK1/2 and PI3K/Akt Signaling Pathways in the Neurite Extension Process

  2015cites this paper
• The neuritogenic and synaptogenic effects of the ethanolic extract of radix Puerariae in cultured rat hippocampal neurons.

  2015cites this paper
• Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application

  2015cites this paper
• Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability.

  2015cites this paper
• Modulation of neurotrophic signaling pathways by polyphenols

  2015cites this paper
• Conditioned Media of Choroid Plexus Epithelial Cells Induces Nrf2-Activated Phase II Antioxidant Response Proteins and Suppresses Oxidative Stress-Induced Apoptosis in PC12 Cells

  2014cites this paper
• Puerarin protects dopaminergic neurons in Parkinson's disease models.

  2014influential citation
• Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease.

  2014cites this paper
• Possible protective action of neurotrophic factors and natural compounds against common neurodegenerative diseases

  2014cites this paper
• Puerarin inhibits growth and induces apoptosis in SMMC-7721 hepatocellular carcinoma cells.

  2014cites this paper
• The Synthesis and characteristic study of transferrin-conjugated liposomes carrying brain-derived neurotrophic factor

  2014cites this paper
• Puerarin Ameliorates 3-Nitropropionic Acid-Induced Neurotoxicity in Rats: Possible Neuromodulation and Antioxidant Mechanisms

  2014cites this paper